학술논문

Potent Graft-versus-Leukemia Effect after Reduced-Intensity Allogeneic SCT for Intermediate-Risk AML with FLT3-ITD or Wild-Type NPM1 and CEBPA without FLT3-ITD
Document Type
Article
Source
In Biology of Blood and Marrow Transplantation December 2012 18(12):1845-1850
Subject
Language
ISSN
1083-8791